Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis

Modern Pathology

Volumn 23, Issue 3, 2010, Pages 480-492

  Straub, Beate K ^a   Herpel, Esther ^a   Singer, Stephan ^a   Zimbelmann, Ralf ^b   Breuhahn, Kai ^a   MacHer Goeppinger, Stephan ^a   Warth, Arne ^a   Lehmann Koch, Judith ^a   Longerich, Thomas ^a   Heid, Hans ^b   Schirmacher, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adipophilin; Hepatocellular carcinoma; Lipid droplet; Perilipin; TIP47; Tissue microarray

Indexed keywords

ADIPOPHILIN; FAT DROPLET; PERILIPIN; PROTEIN PAT; PROTEIN TIP 47; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FATTY LIVER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; LIPOGENESIS; LIVER CELL CARCINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROSCOPY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ADULT; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DNA-BINDING PROTEINS; FATTY LIVER; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASMS; PHOSPHOPROTEINS; PREGNANCY PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77649271067     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.191     Document Type: Article

References (37)

1. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
2. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324: 1029-1033.
3. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-777.
4. Yahagi N, Shimano H, Hasegawa K, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 2005;41:1316-1322.
5. Tennant DA, Durán RV, Boulahbel H, et al. Metabolic transformation in cancer. Carcinogenesis 2009;30: 1269-1280.
6. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006;9:358-365.
7. Yamashita T, Honda M, Takatori H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009;50:100-110.
8. Kutami R, Nakashima Y, Nakashima O, et al. Patho-morphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000;33:282-289.
9. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009;49:658-664.
10. Fujimoto T, Ohsaki Y, Cheng J, et al. Lipid droplets: a classic organelle with new outfits. Histochem Cell Biol 2008;130:263-279.
11. Greenberg AS, Egan JJ, Wek SA, et al. Perilipin, a major hormonally regulated adipocyte-specific phospho-protein associated with the periphery of lipid storage droplets. J Biol Chem 1991;266:11341-11346.
12. Brasaemle DL, Barber T, Wolins NE, et al. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 1997;38:2249-2263.
13. Heid HW, Moll R, Schwetlick I, et al. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res 1998;294:309-321.
14. Wolins NE, Rubin B, Brasaemle DL. TIP47 associates with lipid droplets. J Biol Chem 2001;276:5101-5108.
15. Kimmel AR, Brasaemle DL, McAndrews-Hill M, et al. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular, lipid storage droplet proteins. J Lipid Res 2009; e-pub ahead of print.
16. Martinez-Botas J, Anderson JB, Tessier D, et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 2000;26: 474-479.
17. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001;98:6494-6499.
18. Chang BH, Li L, Paul A, et al. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 2006;26: 1063-1076.
19. Shimizu M, Yamashita D, Yamaguchi T, et al. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation. Mol Cell Biochem 2006;286:33-42.
20. Straub BK, Stoeffel P, Heid H, et al. Differential pattern of lipid droplet-associated proteins and de novo peri-lipin expression in hepatocyte steatogenesis. Hepato-logy 2008;47:1936-1946.
21. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994;91:6379-6383.
22. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumour biology. Nutrition 2000;16:202-208.
23. Yao M, Tabuchi H, Nagashima Y, et al. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 2005;205:377-387.
24. Muthusamy K, Halbert G, Roberts F. Immunohisto-chemical staining for adipophilin, perilipin and TIP47. J Clin Pathol 2006;59:1166-1170.
25. Mrozinski J. Immunhistochemische Identifikation und Klassifizierung von Liposarkomen mittels verschied-ener Fett-assoziierter Proteine. Medical Dissertation. Philipps-University Marburg: Germany, 2007;1-103.
26. Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987;8: 138-140.
27. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
28. Singer S, Ehemann V, Brauckhoff A, et al. Protumouri-genic overexpression of stathmin/Op18 by gain-of-func-tion mutation in p53 in human hepatocarcinogenesis. Hepatology 2007;46:759-768.
29. Izumi M, Mukai K, Nagai T, et al. Sebaceous carcinoma of the eyelids: thirty cases from Japan. Pathol Int 2008;58:483-488.
30. Goodman ZD, Terraciano LM. Tumours and tumourlike lesions of the liver. MacSween's Pathology of the Liver 5th edn. Churchill Livingstone, Elsevier: Philadelphia, 2007;761-814.
31. Kurokawa Y, Matoba R, Nakamori S, et al. PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Ress 2004;23:135-141.
32. Wolins NE, Brasaemle DL, Bickel PE. A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett 2006;580:5484-5491.
33. Tanaka N, Moriya K, Kiyosawa K, et al. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 2008;118:683-694.
34. Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroentero-logy 2007;132:1955-1967.
35. Eastman SW, Yassaee M, Bieniasz PD. A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J Cell Biol 2009;184:881-894.
36. Hall AM, Brunt EM, Chen Z, et al. Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 2009; e-pub ahead of print.
37. Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 2005;23: 4776-4789.